These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4185870)

  • 21. [Prevention of feto-maternal isoimmunizations. Organization in the Marseilles region].
    Nublat M; Dufour Y; Gaujoux J; Alcaraz J; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):209-11. PubMed ID: 4143444
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental and clinical studies on 1st transabdominal flooding of the maternal circulation with fetal erythrocytes (new aspects of Rh sensitization)].
    Hindemann P
    Geburtshilfe Frauenheilkd; 1966 Oct; 26(10):1359-72. PubMed ID: 4162573
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention and anticipation of Rhesus isoimmunization].
    Ravina JH; Poulain M; Lepage F
    Presse Med (1893); 1969 Oct; 77(43):1511-3. PubMed ID: 4187490
    [No Abstract]   [Full Text] [Related]  

  • 24. Rh isoimmunization during pregnancy: antenatal prophylaxis.
    Bowman JM; Chown B; Lewis M; Pollock JM
    Can Med Assoc J; 1978 Mar; 118(6):623-7. PubMed ID: 77714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
    Gherardi A
    Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
    [No Abstract]   [Full Text] [Related]  

  • 26. The importance of antibody concentration, binding constant, and antibody heterogeneity in the suppression of immunity to the Rh factor.
    Pollack W
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):415-21. PubMed ID: 4110458
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunoprophylaxis of neonatal hemolytic disease caused by Rh incompatibility. Analysis of a 5-year experience].
    Sansone G; Veneziano G; Mantegazza F; Cominetti M
    Pathologica; 1974; 66(961-962):477-89. PubMed ID: 4141760
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the effectiveness of anti Rh gamma globulin].
    García Roel R; Santos Martínez A; Salgado Alcocer N
    Ginecol Obstet Mex; 1974 Jan; 35(207):67-73. PubMed ID: 4133289
    [No Abstract]   [Full Text] [Related]  

  • 29. Ten-year experience with high titer anti-D plasma for the prevention of Rh isoimmunization.
    Hamilton EG
    Obstet Gynecol; 1972 Nov; 40(5):692-6. PubMed ID: 4628388
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunological aspects of maternal-fetal iso-immunization].
    Sentíes Gutiérrez L
    Ginecol Obstet Mex; 1970 Feb; 27(160):189-96. PubMed ID: 4191101
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppression of anti-Rh antibodies: mechanism of action and times of administration of the anti-D immunoglobulins].
    Carretti N
    Attual Ostet Ginecol; 1968; 1():181-92. PubMed ID: 4194920
    [No Abstract]   [Full Text] [Related]  

  • 32. The conquest of Rh disease.
    Zipursky A
    Can Med Assoc J; 1978 Mar; 118(6):609-10. PubMed ID: 77713
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trial of one millilitre injections of RH0 (D) immune globulin (human) in the prevention of Rh immunization: preliminary report.
    Bishop GJ; Krieger VI; Tait M; Walsh C
    Med J Aust; 1968 Jun; 1(26):1122-7. PubMed ID: 4174415
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of isoimmunization in the Rh system with anti-D gamma globulin].
    Veselý V
    Cesk Gynekol; 1969 Oct; 34(8):475-6. PubMed ID: 4187684
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of Rh-sensitization by anti-D immunoglobulin. Report of the 3rd meeting of the study group at Freiburg on 27-28 January 1968. II.
    Schneider J
    Ger Med Mon; 1968 Dec; 13(12):613-5. PubMed ID: 4186245
    [No Abstract]   [Full Text] [Related]  

  • 36. [Materno-fetal blood incompatibility caused by Rh factor].
    Krug A
    Rev Chil Obstet Ginecol; 1966; 31(5):231-2. PubMed ID: 4969533
    [No Abstract]   [Full Text] [Related]  

  • 37. [Critical study of the results of an application of preventive treatment taking into account the systematic evaluation of feto-maternal hemorrhage].
    Huchet J; Crégut R; Briffoteaux P; Pinon F
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):203-5. PubMed ID: 4143442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of anti-CD gamma globulin in the prevention of materno-fetal isoimmunization].
    Crespo Cortina M; Arroyo Bornstein A; Olivares Tinajero G
    Ginecol Obstet Mex; 1972 Jan; 31(183):75-81. PubMed ID: 4109103
    [No Abstract]   [Full Text] [Related]  

  • 39. Antenatal prophylaxis of Rh isoimmunization: 28-weeks'-gestation service program.
    Bowman JM; Pollock JM
    Can Med Assoc J; 1978 Mar; 118(6):627-30. PubMed ID: 77715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of the use of immunosuppressive agents based on hyperimmune gamma globulins].
    Crespo Cortina M; Arroyo Bornstein A
    Ginecol Obstet Mex; 1972 Apr; 31(186):369-73. PubMed ID: 4112876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.